Sort
51,593 grants matching “hepatitis”
Hepatitis B Research Network - Data Coordination Center
$2,822,874Steven H. Belle · University Of Pittsburgh At Pittsburgh · U01 · FY2018 · DK
Southern California Women's Interagency HIV Study Consortium
$2,819,748Marek Jan Nowicki · University Of Southern California · U01 · FY2011 · HD
Pathogenesis and Novel Therapeutic Targets of Fatty Liver Disease and Cancer
$2,809,173Bin Gao · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2024 · AA
Cancer Risk in Human Populations
$2,806,276Debra Silverman · Division Of Cancer Epidemiology And Genetics · ZIA · FY2014 · CA
Stroke with Transfusions Changing to Hydroxyurea
$2,804,348Russell E Ware · St. Jude Children'S Research Hospital · U01 · FY2007 · HL
Childhood Liver Disease Research Network Data Coordinating Center
$2,800,068John C Magee · University Of Michigan At Ann Arbor · U01 · FY2014 · DK
MULTICENTER AIDS COHORT STUDY
$2,799,416John P Phair · Howard Brown Health Center · U01 · FY2006 · AI
Appalachian Node
$2,799,142Jane M Liebschutz · University Of Pittsburgh At Pittsburgh · UG1 · FY2019 · DA
GENERAL CLINICAL RESEARCH CENTER
$2,796,869University Of Texas Sw Med Ctr/Dallas · M01 · FY2002 · RR
Southern California Women's Interagency HIV Study Consortium
$2,795,907Joel E Milam · University Of Southern California · U01 · FY2012 · HD
Emerging Infections Programs
$2,793,784Richard Norman Danila · Minnesota State Dept Of Health · U01 · FY2007 · CI
Vaccine and Treatment Evaluation Unit at Saint Louis University
$2,792,722Daniel F. Hoft · Saint Louis University · UM1 · FY2025 · AI
The FIOCRUZ Therapeutic and Prevention HIV/AIDS Clinical Trials Unit.
$2,790,912Beatriz Grinsztejn · Fundacao Oswaldo Cruz · UM1 · FY2021 · AI
Studies of Rare Cancers
$2,789,746Katherine McGlynn · Division Of Cancer Epidemiology And Genetics · ZIA · FY2022 · CA
The Johns Hopkins Baltimore-Washington-India Clinical Trials Unit (BWI CTU)
$2,786,855Charles W. Flexner · Johns Hopkins University · UM1 · FY2020 · AI
Connecticut Emerging Infections Program
$2,784,816Matthew Lewis Cartter · Connecticut State Dept Of Public Health · U01 · FY2011 · CI
Emory- Duke- Orlando- CDC (EmDOC) Clinical Trials Unit
$2,783,692Jeffrey Lennox · Emory University · UM1 · FY2018 · AI
Harvard/Boston/Providence Clinical Trials Unit (Harvard/B/P CTU)
$2,781,833Raphael Dolin · Beth Israel Deaconess Medical Center · UM1 · FY2015 · AI
Molecular profiling and immunomodulatory interventions
$2,780,168Abraham Na Shaked · University Of Pennsylvania · U01 · FY2007 · AI
Childhood Liver Disease Research Network Data Coordinating Center
$2,780,000John C Magee · University Of Michigan At Ann Arbor · U24 · FY2019 · DK
1/2 Sickle Cell Disease and CardiovAscular Risk - Red cell Exchange Trial (SCD-CARRE Trial)
$2,775,824Mark Thomas Gladwin · University Of Pittsburgh At Pittsburgh · UH3 · FY2020 · HL
Synergies among inhibitory receptors in tolerance and disease
$2,775,439Dario Aa Vignali · University Of Pittsburgh At Pittsburgh · P01 · FY2025 · AI
WOMENS INTERAGENCY HIV STUDY
$2,770,576Suny Downstate Medical Center · U01 · FY2002 · AI
Impact of CCR5 Blockade in HIV+ Kidney Transplant Recipients
$2,764,135Peter G Stock · University Of California, San Francisco · U01 · FY2019 · AI
Viral Hemorrhagic Fevers: Disease Modeling and Transmission
$2,762,918Heinrich Feldmann · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI